[Federal Register Volume 87, Number 169 (Thursday, September 1, 2022)]
[Notices]
[Page 53714]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18900]



[[Page 53714]]

-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-18-2022]


Foreign-Trade Zone (FTZ) 22--Chicago, Illinois, Authorization of 
Production Activity, AbbVie, Inc. (Pharmaceutical Products), Chicago, 
Illinois

    On April 29, 2022, AbbVie, Inc., submitted a notification of 
proposed production activity to the FTZ Board for its facility within 
Subzone 22S, in Chicago, Illinois.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (87 FR 27563, May 9, 2022). On August 
29, 2022, the applicant was notified of the FTZ Board's decision that 
no further review of the activity is warranted at this time. The 
production activity described in the notification was authorized, 
subject to the FTZ Act and the FTZ Board's regulations, including 
section 400.14.

    Dated: August 29, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-18900 Filed 8-31-22; 8:45 am]
BILLING CODE 3510-DS-P